How does Prevnar 13 differ from the pneumococcal polysaccharide vaccine?

Advertisement
Advertisement
The pneumococcal polysaccharide vaccine is used in both adults and children. Because of the difference in the type of antigens in the two vaccines, Prevnar 13 (pneumococcal conjugate vaccine) is able to elicit immunity to S. pneumococcal bacteria at a much younger age than the pneumococcal polysaccharide vaccine. Because S. pneumonococcal bacteria is a leading cause of severe infections (including pneumonia, meningitis, bacteremia and ear infections) in young children, being able to immunize children at an earlier age helps to prevent a significant number of cases that the polysaccharide vaccine cannot prevent.

Continue Learning about Vaccine

Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.